Activin-actriia antagonists and uses for treating multiple myeloma
US-2021261682-A1 · Aug 26, 2021 · US
This patent family groups 3 related publications across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 39690668 |
| Family type | — |
| Earliest priority | Nov 23, 2005 |
| First filing country | US |
| Member publications | 3 |
| Countries | US |
| Representative publication | US2021261682A1 — Activin-actriia antagonists and uses for treating multiple myeloma |
Best representative member for this family based on priority and filing country.
US2021261682A1 — Activin-actriia antagonists and uses for treating multiple myeloma (published Aug 26, 2021)
Related publications in this family.
US-2021261682-A1 · Aug 26, 2021 · US
US-2017190784-A1 · Jul 6, 2017 · US
US-9572865-B2 · Feb 21, 2017 · US